Luca Sancineto

Dr. Luca Sancineto

University of Perugia, Department of pharmaceutical sciences
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
RCRolando Cannalire
Rolando Cannalire
SPSveva Pelliccia
Sveva Pelliccia
Luca SancinetoLuca Sancineto
Luca Sancineto
ENEttore Novellino
Ettore Novellino
gian cesare trongian cesare tron
gian cesare tron
mariateresa giustinianomariateresa giustiniano
mariateresa giustiniano
Recent developments and future prospects of visible-light photocatalysis in the late-stage functionalization of pharmaceuticals and natural bioactive compounds.

1 January 2018
Verified
Book
Closed access
Eder LenardaoEder Lenardao
Eder Lenardao
Claudio SantiClaudio Santi
Claudio Santi
Luca SancinetoLuca Sancineto
Luca Sancineto

10 December 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Luca SancinetoLuca Sancineto
Luca Sancineto
AMAlice Mariotti
Alice Mariotti
LBLuana Bagnoli
Luana Bagnoli
Francesca MariniFrancesca Marini
Francesca Marini
JDJenny Desantis
Jenny Desantis
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini

14 July 2014 in RSC Advances
Verified
Journal Article
Closed access
PDF file
SSStefano Santoro
Stefano Santoro
JAJuliano B. Azeredo
Juliano B. Azeredo
VANESSA NASCIMENTOVANESSA NASCIMENTO
VANESSA NASCIMENTO
Luca SancinetoLuca Sancineto
Luca Sancineto
ABAntonio Braga
Antonio Braga
Claudio SantiClaudio Santi
Claudio Santi
Key aspects for the development of a greener synthesis and the use of the organoselenium compounds.

2 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Davide Benedetto TizDavide Benedetto Tiz
Davide Benedetto Tiz
LBLuana Bagnoli
Luana Bagnoli
OROrnelio Rosati
Ornelio Rosati
Francesca MariniFrancesca Marini
Francesca Marini
Luca SancinetoLuca Sancineto
Luca Sancineto
Claudio SantiClaudio Santi
Claudio Santi
This review describes the recent Food and Drug Administration (FDA)-approved drugs (in the year 2021) containing at least one halogen atom (covalently bound). The structures proposed throughout this work are grouped according to their therapeutical use. Their synthesis is presented as well. The number of halogenated molecules that are reaching the market is regularly preserved, and 14 of the 50 molecules approved by the FDA in the last year contain halogens. This underlines the emergent role of halogens and, in particular, of fluorine and chlorine in the preparation of drugs for the treatment of several diseases such as viral infections, several types of cancer, cardiovascular disease, multiple sclerosis, migraine and inflammatory diseases such as vasculitis.
1

1 January 2017
Verified
Book Chapter
Closed access
DBDesirée Bartolini
Desirée Bartolini
Luca SancinetoLuca Sancineto
Luca Sancineto
MMMaria Monsalve
Maria Monsalve
KTKenneth D Tew
Kenneth D Tew
Claudio SantiClaudio Santi
Claudio Santi
FGFrancesco Galli
Francesco Galli